These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 31618159)

  • 1. Re: Oncologic Outcomes following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses.
    Laguna MP
    J Urol; 2020 Jan; 203(1):27-28. PubMed ID: 31618159
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Oncologic Outcomes following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses.
    Cadeddu JA
    J Urol; 2020 Jan; 203(1):28. PubMed ID: 31618160
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: Jack R. Andrews, Thomas Atwell, Grant Schmit, et al. Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses. Eur Urol 2019;76:244-51.
    Pecoraro A; Porpiglia F; Karakiewicz PI
    Eur Urol; 2020 Mar; 77(3):e74. PubMed ID: 31607394
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: Comparison of Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses.
    Laguna MP
    J Urol; 2015 Aug; 194(2):331. PubMed ID: 26195356
    [No Abstract]   [Full Text] [Related]  

  • 5. Re: R. Houston Thompson, Tom Atwell, Grant Schmit, et al. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses. Eur Urol 2015;67:252-9.
    Mouracade P
    Eur Urol; 2015 Oct; 68(4):e82-3. PubMed ID: 26033152
    [No Abstract]   [Full Text] [Related]  

  • 6. Re: R. Houston Thompson, Tom Atwell, Grant Schmit, et al. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses. Eur Urol 2015;67:252-9.
    Potretzke AM; Larson JA; Bhayani SB
    Eur Urol; 2015 Feb; 67(2):e19-20. PubMed ID: 25269382
    [No Abstract]   [Full Text] [Related]  

  • 7. Re: R. Houston Thompson, Tom Atwell, Grant Schmit, et al. Comparison of Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses. Eur Urol 2015;67:252-9.
    Zargar H; Coelho RF; Kaouk JH
    Eur Urol; 2015 Feb; 67(2):e23. PubMed ID: 25266972
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses.
    Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
    Eur Urol; 2015 Feb; 67(2):252-9. PubMed ID: 25108580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reply to Pascal Mouracade's letter to the editor re: R. Houston Thompson, Tom Atwell, Grant Schmit, et al. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses. Eur Urol 2015;67:252-9.
    Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
    Eur Urol; 2015 Oct; 68(4):e84-5. PubMed ID: 26058957
    [No Abstract]   [Full Text] [Related]  

  • 10. Reply to Homayoun Zargar, Rafael F. Coelho and Jihad H. Kaouk's Letter to the Editor re: R. Houston Thompson, Tom Atwell, Grant Schmit, et al. Comparison of Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses. Eur Urol 2015;67:252-9.
    Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
    Eur Urol; 2015 Feb; 67(2):e24-5. PubMed ID: 25257032
    [No Abstract]   [Full Text] [Related]  

  • 11. Reply to Aaron M. Potretzke, Jeffrey A. Larson and Sam B. Bhayani's Letter to the Editor re: R. Houston Thompson, Tom Atwell, Grant Schmit, et al. Comparison of Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses. Eur Urol 2015;67:252-9.
    Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
    Eur Urol; 2015 Feb; 67(2):e21-2. PubMed ID: 25257031
    [No Abstract]   [Full Text] [Related]  

  • 12. [Radiofrequency ablation of renal cell carcinoma].
    Estébanez Zarranz J; Artozki Morras E; Aguirreazaldegui García L; Crespo Crespo I; Bandrés Iruretagoyena F; Sanz Jaka JP
    Actas Urol Esp; 2009 Jan; 33(1):35-42. PubMed ID: 19462723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contemporary Status of Percutaneous Ablation for the Small Renal Mass.
    Shin BJ; Chick JF; Stavropoulos SW
    Curr Urol Rep; 2016 Mar; 17(3):23. PubMed ID: 26874535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ASO Author Reflections: Thermal Ablation Versus Partial Nephrectomy for cT1 Renal Mass in a Solitary Kidney: A Matched Cohort Comparative Analysis.
    Attawettyanon W; Campbell SC
    Ann Surg Oncol; 2024 Mar; 31(3):2173-2174. PubMed ID: 38161201
    [No Abstract]   [Full Text] [Related]  

  • 15. Radio frequency ablation versus partial nephrectomy for clinical T1b renal cell carcinoma: long-term clinical and oncologic outcomes.
    Chang X; Zhang F; Liu T; Ji C; Zhao X; Yang R; Yan X; Wang W; Guo H
    J Urol; 2015 Feb; 193(2):430-5. PubMed ID: 25106899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous ultrasound-guided radiofrequency ablation of recurrent renal cell carcinoma in renal allograft after partial nephrectomy.
    Goeman L; Joniau S; Oyen R; Van Poppel H
    Urology; 2006 Jan; 67(1):199. PubMed ID: 16413367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re: An et al.: Partial vs Radical Nephrectomy for T1-T2 Renal Masses in the Elderly: Comparison of Complications, Renal Function, and Oncologic Outcomes (Urology 2017;100:151-157).
    Panaiyadiyan S; Kumar R
    Urology; 2017 May; 103():274. PubMed ID: 28237531
    [No Abstract]   [Full Text] [Related]  

  • 18. Systematic review and meta-analysis of thermal ablation versus surgical nephrectomy for small renal tumours.
    Katsanos K; Mailli L; Krokidis M; McGrath A; Sabharwal T; Adam A
    Cardiovasc Intervent Radiol; 2014 Apr; 37(2):427-37. PubMed ID: 24482030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous radiofrequency ablation for renal cell carcinoma vs. partial nephrectomy: Comparison of long-term oncologic outcomes in both clear cell and non-clear cell of the most common subtype.
    Liu N; Huang D; Cheng X; Chong Y; Wang W; Gan W; Guo H
    Urol Oncol; 2017 Aug; 35(8):530.e1-530.e6. PubMed ID: 28408296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CIRSE Guidelines on Percutaneous Ablation of Small Renal Cell Carcinoma.
    Krokidis ME; Orsi F; Katsanos K; Helmberger T; Adam A
    Cardiovasc Intervent Radiol; 2017 Feb; 40(2):177-191. PubMed ID: 27987000
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.